ophthalmologytimes14h
Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
Bausch + Lomb Shares Rise on FDA Approval of enVista Envy Intraocular Lens
Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...
ophthalmologytimes21h
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
Daily Monitor21h
Why selecting the right eyeglasses is key
For her, comfort is key, and she does not mind searching through multiple shops to find the perfect frame. She believes that ...
Bausch + Lomb's enVista Envy Intraocular Lens Gets FDA Approval
Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...